Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Rönesans Holding Looks Ahead to 2024 with Robust Growth and Strategic Expansion Plans

Published

on

ronesans-holding-looks-ahead-to-2024-with-robust-growth-and-strategic-expansion-plans

ISTANBUL, Feb. 2, 2024 /PRNewswire/ —

  • Rönesans expects to end 2023 with a revenue of €3.3billion, representing a 10% increase on 2022.
  • Rönesans ceased its operations in Russia and is now focusing on an ambitious growth strategy worldwide. The company aims to invest into new markets and sectors and capitalise on its extensive experience in healthcare, the energy transition, and commercial buildings.
  • In anticipation of a strong year in 2024, Rönesans Holding remains dedicated to upholding responsible growth and contributing to the impact economy, prioritising innovation, technical expertise, international experience, sustainability, and the implementation of robust health, safety, and environmental procedures.
  • Working with its global partners and a variety of international financial institutions; Rönesans has expanded its operations globally with a focus on contributing to local economies through its construction projects.

Rönesans, a leading global contracting and investment group, expecting a revenue of €3.3billion in 2023, has today unveiled its review of 2023 performance, 2024 outlook and strategic expansion plans as it continues to establish itself as a key player in the impact economy.

 

 

The group’s dedication to innovation, environmental responsibility, sustainable energy transition, and strategic investments enabled it to expand its footprint in important economic sectors in 2023, including energy transition, sustainable living, renewable energy, healthcare, and transportation infrastructure.

2023 Review

Despite global and local challenges, Rönesans concluded the year with financial and social achievements, demonstrating strong and sustainable business growth and solidifying its position as one of Europe’s top ten international construction companies.

Expecting to end 2023 with a revenue of €3.3billion, representing a 10% increase on 2022, Rönesans ensured a strong performance despite significant financial headwinds experienced throughout the year.

In 2023, Rönesans deepened its relationships with international partners and embarked on several new collaborations and investments, showcasing its successful implementation of the EPC-F (Engineering, Procurement, Construction, and Financing) model. These include the financing agreement with the UK government’s export credit agency (UKEF) on behalf of the Turkish Ministry of Transport, which has underwritten €781m of funding (equivalent to £680m) of the €923 million total project financing for the complete construction of a high-speed electrified railway connecting Turkiye’s second-largest container port in Mersin with the inland cities of Adana, Osmaniye and Gaziantep. It promises faster, more efficient transit over a distance greater than Paris to Brussels, boosting regional infrastructure and growth.

Furthermore, Rönesans also announced its agreement with TotalEnergies, in which TotalEnergies acquired a 50% stake in Rönesans Enerji and committed to jointly produce 2 GW of renewable energy capacity by 2028, worth US$2billion. The agreement is one of the latest in Rönesans Holding’s long history of successful strategic partnerships from all around the world. The company has collaborated with various partners and shareholders, including Government of Singapore Investment Corporation (GIC), Meridiam, a Paris-based infrastructure fund, Japanese trading house Sojitz Corporation, and International Finance Corporation (IFC), of the World Bank Group which is a shareholder in Rönesans, and Samsung C&T, among others.

Likewise, Rönesans has made significant progress with approximately €2.5billion financing of its pipeline projects, including the Ceyhan Polypropylene Production Plant, the Nakkaş-Başakşehir Highway Project, and the RERA-Wind projects.

On the international front, Rönesans is approaching the completion of the project development phase for its inaugural hospital in Kazakhstan. This hospital will be the first healthcare facility in Kazakhstan to be developed under the Public-Private Partnership (PPP) model. This project marks a crucial step towards realising transformative healthcare initiatives on an international stage.

As a company with a global footprint, Rönesans is generating more than 30% of its revenues from Europe via Ballast Nedam, Rönesans’ longstanding Dutch arm, which is not only active in the Dutch market but also has projects from Caribbean to Sri Lanka.

Bridges, tunnels, utility buildings, ports, houses and highways

Every day, Ballast Nedam builds and develops sustainable and often iconic landmarks that positively contribute to society. One such project is the A24 Blankenburgverbinding. Rijkswaterstaat commissioned Ballast Nedam and consortium partners DEME and Macquarie Capital to build the 4 kilometer-long new highway and surrounding infrastructure. The contract includes the design, construction, 20 years of maintenance, and approximately €1 billion in financing. With two junctions, a land tunnel and a tunnel beneath the river Het Scheur, Ballast Nedam will play a key role in improving the accessibility of the Rotterdam region and contribute to the growth of the economy.

Over the course of 2024, Ballast Nedam, will continue to grow by focusing on energy transformation, sustainable living, and the renewal of European infrastructure projects. Sustainable construction and development are one of the biggest focuses for Ballast Nedam. Besides working towards 100% CO2-neutral construction sites by 2030, their ambition for 2040 is to transition to energy-neutral construction.

Ballast Nedam has also reached a crucial milestone in another major project with the successful immersion of the tunnel sections of the Maasdeltatunnel. This marks a historic occasion, as tunnel sections of this size have not been built and immersed before in the Netherlands. An immersed tunnel is an underwater passage constructed from tunnel elements that were fabricated elsewhere. These elements are then floated and towed to the tunnel alignment, where they are submerged and interconnected. Successfully immersing the tunnel sections of the Maasdeltatunnel is a precise, controlled and challenging operation that requires technical expertise and innovative thinking, requiring the temporary closure of one of the world’s busiest waterways.

In Russia, Rönesans divested its construction business in May 2022 and its real estate business in June 2023, redirecting investment and attention to diverse locations worldwide. This transition and the strategic decision to pivot away from direct management in that market has transformed Rönesans’ growth strategy. The group’s global footprint now extends to various regions, anchored in Turkey and spanning the Netherlands, Germany and CIS countries, with a growing focus on Kazakhstan and Turkmenistan.

These projects, underscore Rönesans’ commitment to driving growth, sustainability and fostering international relationships. With its focus on reducing environmental impact and regenerating infrastructure Rönesans has shown it is a dynamic and forward-thinking business, poised for a prosperous future.

Local impact

In February 2023, the company responded promptly to provide humanitarian support in the aftermath of the devastating earthquakes in Gaziantep-Kahramanmaraş. Notably, UNICEF and Rönesans Group joined forces to establish Child, Adolescent, and Family Support Hubs within temporary living spaces built and designed for more than 10,000 people by Rönesans Holding in Malatya, Turkey. These hubs aim to provide essential services and support to those affected by the disaster, offering psychosocial well-being, education, and overall development. The Rönesans team constructed container cities in the region to accommodate tens of thousands of earthquake victims one month after the devastating earthquakes in the region.

With Rönesans’ intentions to support earthquake stricken areas a key part of its 2023 agenda, the completion of the Gaziantep Hospital project, taken over by Rönesans and Meridiam in September 2022, stands out as another remarkable achievement. Finalised in 11 months ahead of schedule by Rönesans Construction in 2023 the project was implemented in collaboration with Rönesans Healthcare Investment, Samsung C&T, Meridiam, and İstanbul Asset Management. An international collaborative success, this marks the sixth city hospital completed under the PPP scheme by Rönesans Holding, representing approximately 35% of the market. With a total capacity of 1,875 beds, Gaziantep City Hospital is designed to provide world-class healthcare services across Southern Turkey and the wider region.

2024 Outlook

İpek Ilıcak Kayaalp, Chair of the Board of Directors of Rönesans, commented, “In 2024, Rönesans Holding will continue to focus its investments and attention on innovation, global growth, sustainable living and the energy transition, as well as maintaining operational excellence. With our strategic pivot, we are confident that we’ll make good progress with our expansion plans in 2024, setting ourselves up for long-term growth.”

Looking ahead to 2024, the company will continue to deliver on its commitment to responsible growth and the impact economy, prioritising innovation, technical and international experience and health, safety and environment procedures.

Ceasing operations in Russia, Rönesans is planning to expand into new markets, growing its global presence and leveraging its expertise in healthcare, energy and commercial construction. Recognising the challenges in the contractor landscape, Rönesans is also proactively addressing financial pressures, focusing on cost optimisation for customers without compromising on quality, ensuring sustainability and profitability.

The group has set a target turnover of €4.5 billion for 2024, expecting strong growth from construction revenues stemming from international and local investments projects spanning hospitals and windfarms.

2024 will also be the year Rönesans takes its first step towards opening to the public, announcing the IPO process of Rönesans Real Estate Investment. This IPO will be the first of potentially many others, as momentum grows for Rönesans Group.

With strong business growth in its sights for 2024, Rönesans will still continue to support earthquake relief efforts and humanitarian projects, responding to the needs of vulnerable members of society.

About Rönesans Group 

Rönesans Holding, the conglomerate’s top investment entity headquartered in Ankara, is the 38th largest international contracting company globally and the 9th largest in Europe. With operations spanning 30 countries across Europe, Central Asia, and Africa, including subsidiaries such as Ballast Nedam in the Netherlands and Heitkamp Industrial Solutions GmbH in Germany, Rönesans has been operating as the main contractor and investor successfully for 30 years in construction, real estate development, healthcare and energy. Putting resilience and growth through innovation at the core of the company, with a priority on sustainability and social development, Rönesans has developed projects supporting students with scholarships, academic platforms and initiatives; been a signatory of the UN Global Compact since 2015; and a signatory of the UN Women’s Empowerment Principles since 2016. 

Along with its partners GIC, Meridiam Infrastructure, Sojitz, Samsung C&T, TotalEnergies, and IFC of the World Bank Group (minority shareholder in the group), Rönesans has invested more than EUR8 billion into pioneering projects globally.

Photo: https://mma.prnewswire.com/media/2332276/Ronesans_Holding.jpg
Logo: https://mma.prnewswire.com/media/2186431/Ronesans_Holding_Logo.jpg

 

Rönesans Holding Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/ronesans-holding-looks-ahead-to-2024-with-robust-growth-and-strategic-expansion-plans-302051172.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending